Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Neoplasms of the CNS

  Free Subscription


14.09.2026

1 Acta Neuropathol
1 AJNR Am J Neuroradiol
6 Childs Nerv Syst
1 J Natl Cancer Inst
8 J Neurooncol
1 J Neurosurg
6 Neuro Oncol
1 Neurol Res
1 Neuroradiology
1 Neurosurgery
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. ZAYTSEVA M, Papusha L, Druy A
    Concurrent substitutions H3 S28C or S31C/Y in H3 K27-altered diffuse midline gliomas may represent mutation bias, apart from being a source of potential diagnostic pitfall. Scientific commentary on: "H3K27ME3 loss in diffuse midline gliomas lacking H3
    Acta Neuropathol. 2026;152:33.
    PubMed        


    AJNR Am J Neuroradiol

  2. SALIM HA, Calabrese E, Naeem A, Eldaya R, et al
    MRI Radiomics for Survival Prediction in Brain Metastases: A Machine Learning Analysis.
    AJNR Am J Neuroradiol. 2026 Sep 9:ajnr.A9630. doi: 10.3174/ajnr.A9630.
    PubMed         Abstract available


    Childs Nerv Syst

  3. WU W, Mo F, Guo G, Sun Z, et al
    Middle cranial fossa Sylvian fissure arachnoid cysts in infants younger than 1 year: clinical characteristics, preoperative growth patterns, and outcomes of endoscopic fenestration.
    Childs Nerv Syst. 2026;42:360.
    PubMed         Abstract available

  4. MUHAMMAD SALEEM M, Ibrahim HY
    Letter to the editor: pediatric meningioma and seizures: a single center cohort study.
    Childs Nerv Syst. 2026;42:361.
    PubMed        

  5. BOUBEKRI M, Cherradi N
    Pediatric low-grade glial, glioneuronal and neuronal tumors: a retrospective study of 85 cases.
    Childs Nerv Syst. 2026;42:358.
    PubMed         Abstract available

  6. KARDAS N, Sztuba K, Wyroba N, Putz M, et al
    Spontaneous complete regression of congenital brain tumors - a systematic literature review and case report.
    Childs Nerv Syst. 2026;42:359.
    PubMed         Abstract available

  7. FARAH R, Farah R, Charro E, Bedran J, et al
    Efficacy and safety of trametinib use in pediatric brain tumors in a low- to middle-income country.
    Childs Nerv Syst. 2026;42:357.
    PubMed         Abstract available

  8. HARARY PM, Hori YS, Tan SK, Mahaney K, et al
    Recurrent C19MC-altered embryonal tumors with multilayered rosettes: outcomes of stereotactic radiosurgery.
    Childs Nerv Syst. 2026;42:356.
    PubMed         Abstract available


    J Natl Cancer Inst

  9. SULLIVAN SM, Lane J, Standafer A, Mcfeeters J, et al
    Overlapping genetic etiology of pediatric and adult germ cell tumors.
    J Natl Cancer Inst. 2026;118:1657-1669.
    PubMed         Abstract available


    J Neurooncol

  10. GONZALEZ-VAZQUEZ A, Lorenzana-Mendoza NA, Reyes Perez JA, Cacho-Diaz B, et al
    Prognostic value of the Evans index in neoplastic meningitis: a real-world cohort study.
    J Neurooncol. 2026;179:71.
    PubMed         Abstract available

  11. DEMIRCAN V
    Treatment selection or treatment effect? Interpreting functional outcomes in motor cortex metastases.
    J Neurooncol. 2026;179:72.
    PubMed         Abstract available

  12. DUZKALIR AH, Askeroglu MO, Yildirim DC, Marciniuk K, et al
    Stereotactic radiosurgery for brain metastases from male breast cancer: a multicenter retrospective study.
    J Neurooncol. 2026;179:73.
    PubMed         Abstract available

  13. ROUX A, Zanello M, Pallud J
    Contrast enhancement: the missing imaging variable in IDH-wildtype gliomas with historical WHO grade 2 and 3 histology.
    J Neurooncol. 2026;179:74.
    PubMed        

  14. LOXTERKAMP E, Luo A, Sanvito F, Le CT, et al
    Diffusion histogram analysis predicts progression-free survival in contrast enhancing recurrent IDH mutant gliomas treated with bevacizumab.
    J Neurooncol. 2026;179:75.
    PubMed         Abstract available

  15. TOKIWA S, Natsume K, Yoshida A, Yonezawa H, et al
    Prognostic significance of walking ability at hospital discharge for overall survival in newly diagnosed glioblastoma: a comparison across six peri-treatment assessments.
    J Neurooncol. 2026;179:78.
    PubMed         Abstract available

  16. TOS SM, Kollia S, Mantziaris G, Maragkos GA, et al
    Meningiomas classified as grade 2 due to brain invasion alone have better progression-free survival than other atypical meningiomas.
    J Neurooncol. 2026;179:79.
    PubMed         Abstract available

  17. SENTURK E, Erpolat P, Kamer S, Yucel B, et al
    Long-term outcomes after adjuvant radiotherapy in adult spinal ependymomas: a multicenter study by the trod Neuro-Oncology research group (07 - 005).
    J Neurooncol. 2026;179:77.
    PubMed         Abstract available


    J Neurosurg

  18. BROECHNER A, Rehne Jensen L, Juratli TA, Maier AD, et al
    Increased risk of early recurrence after gross-total resection in males with a WHO grade II meningioma: the impact of sex on recurrence and death in 5441 meningioma patients.
    J Neurosurg. 2026 Sep 11:1-14. doi: 10.3171/2026.3.JNS252398.
    PubMed         Abstract available


    Neuro Oncol

  19. HE Q, Wu R, Yu X, Song X, et al
    EFTUD2-Regulated Alternative Splicing of MSH5 Drives Radioresistance in Recurrent IDH-Mutant Glioma.
    Neuro Oncol. 2026 Sep 9:noag225. doi: 10.1093.
    PubMed         Abstract available

  20. MACHINGURA A, Weller J, Koekkoek JAF, Dirven L, et al
    Association between temozolomide-related hematologic toxicity and health-related quality of life (HRQoL) in patients with newly diagnosed glioblastoma.
    Neuro Oncol. 2026 Sep 8:noag224. doi: 10.1093.
    PubMed         Abstract available

  21. ZENG D, Snyder AZ, Park KY, Acland BT, et al
    Functional clustering within glioblastoma identifies a network-integrated subtype with improved survival.
    Neuro Oncol. 2026 Sep 8:noag223. doi: 10.1093.
    PubMed         Abstract available


  22. Corrigendum to: DeltaNp73/ETS2 complex drives glioblastoma pathogenesis-targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.
    Neuro Oncol. 2026 Sep 8:noag208. doi: 10.1093.
    PubMed        

  23. CALAMINUS G, Alapetite C, Kortmann RD, Ajithkumar T, et al
    Final report of the SIOP-CNS-GCT II protocol for germinoma: Omitting radiotherapy boost is safe in localized disease in complete remission after chemotherapy.
    Neuro Oncol. 2026;28:2234-2247.
    PubMed         Abstract available

  24. BENANTEUR N, Villa C, Bioletto F, Birtolo MF, et al
    Genomic characterization of aggressiveness in pituitary neuroendocrine tumors.
    Neuro Oncol. 2026;28:2166-2179.
    PubMed         Abstract available


    Neurol Res

  25. WEN W, Zhang X, Yue L
    An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
    Neurol Res. 2026 Sep 8:1-14. doi: 10.1080/01616412.2026.2730581.
    PubMed         Abstract available


    Neuroradiology

  26. LIANG X, Wang L, Xiao K, Diao H, et al
    Multiparametric static hybrid (1)(8)F-FET PET/MR for preoperative prediction of TERT promoter mutation in glioblastoma.
    Neuroradiology. 2026 Sep 9. doi: 10.1007/s00234-026-04077.
    PubMed         Abstract available


    Neurosurgery

  27. RAMINA R, da Silva EB Jr, Jung GS, Farah HO, et al
    Binary 5-Aminolevulinic Acid Classification Integrated With Simpson Grading in Meningioma Surgery: A Single-Center Retrospective Series of 265 Cases.
    Neurosurgery. 2026 Sep 11. doi: 10.1227/neu.0000000000004209.
    PubMed         Abstract available


    PLoS One

  28. ISMAILOV A, Poptsova M
    Pericyte-derived cancer-associated fibroblasts correlate with poor survival and are enriched after chemoradiotherapy in glioblastoma.
    PLoS One. 2026;21:e0355902.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum